PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 17 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $10,017,000 | -55.9% | 10,000,000 | -55.3% | 0.01% | -42.9% |
Q1 2022 | $22,729,000 | -18.5% | 22,383,000 | -15.2% | 0.02% | -8.7% |
Q4 2021 | $27,902,000 | +1.6% | 26,383,000 | 0.0% | 0.02% | -8.0% |
Q3 2021 | $27,474,000 | +6.9% | 26,383,000 | +10.5% | 0.02% | +13.6% |
Q2 2021 | $25,711,000 | -6.8% | 23,883,000 | 0.0% | 0.02% | -18.5% |
Q1 2021 | $27,592,000 | -10.1% | 23,883,000 | 0.0% | 0.03% | 0.0% |
Q4 2020 | $30,704,000 | +13.1% | 23,883,000 | 0.0% | 0.03% | -3.6% |
Q3 2020 | $27,136,000 | +73.7% | 23,883,000 | +77.7% | 0.03% | +47.4% |
Q2 2020 | $15,625,000 | +138.6% | 13,443,000 | +126.2% | 0.02% | +90.0% |
Q1 2020 | $6,548,000 | -32.7% | 5,943,000 | -29.6% | 0.01% | -9.1% |
Q4 2019 | $9,732,000 | +11.0% | 8,443,000 | 0.0% | 0.01% | 0.0% |
Q3 2019 | $8,768,000 | -16.9% | 8,443,000 | -10.6% | 0.01% | -15.4% |
Q2 2019 | $10,552,000 | +7.9% | 9,443,000 | 0.0% | 0.01% | 0.0% |
Q1 2019 | $9,776,000 | – | 9,443,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DeepCurrents Investment Group LLC | 31,204,000 | $31,610,000 | 0.98% |
Opti Capital Management, LP | 8,000,000 | $8,206,000 | 0.66% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 14,527,000 | $15,076,000 | 0.34% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 15,519,000 | $15,848,000 | 0.31% |
CSS LLC/IL | 7,007,000 | $7,112,000 | 0.26% |
WOLVERINE ASSET MANAGEMENT LLC | 17,479,000 | $17,762,000 | 0.17% |
LMR Partners LLP | 9,500,000 | $9,933,000 | 0.12% |
PALISADE CAPITAL MANAGEMENT, LP | 4,672,000 | $4,858,000 | 0.11% |
Verition Fund Management LLC | 8,091,000 | $8,233,000 | 0.10% |
Aequim Alternative Investments LP | 2,000,000 | $2,035,000 | 0.05% |